Explore evidence

73 %HIV RNA less than 50 copies/ml at 24 weeks was observed in 64 of 88 (73%) patients in the combined FZD arms.

Côte d'IvoireVIH/sidapublished 2017AIDS (London, England)europe_pmcdocument of 7 observations

67.5 %Of 422 HIV-2-infected patients, 285 (67.5%) were treated with a boosted PI-based regimen.

Côte d'IvoireVIH/sidapublished 2016Journal of the International AIDS Societyeurope_pmcdocument of 6 observations

165 cells/mm³The median CD4 count at antiretroviral therapy initiation among HIV-2 infected patients was 165 cells/mm³.

Côte d'IvoireVIH/sidapublished 2014BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/1471-2334-14-461

17.7 aORHIV infection was associated with anogenital cancer (aOR 17.7 [CI 6.9-45.2]).

Côte d'Ivoireanogenital cancer · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations

44 yearsThe median age at antiretroviral therapy initiation among HIV-2 infected patients was 44 years.

Côte d'IvoireVIH/sidapublished 2014BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/1471-2334-14-461

60 %Among HIV-2 patients, the prevalence of advanced HIV disease was 60.0% among those who were dead or lost to follow-up.

Côte d'IvoireVIH avancé · VIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

Patients who experienced severe morbidity had higher risks of mortality, virological failure and immunological failure.

Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations

146 cells/mm³The median CD4 count at ART initiation was 146 cells/mm³ among dually seropositive patients.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

11.7 %Among 344 HIV-infected pregnant women who conceived on antiretroviral therapy, the overall proportion of abortion was 11.7%.

Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

84 %HIV-2 resistance mutations to nucleoside reverse transcriptase inhibitors were detected in 21 of 25 (84%) samples.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations

From months 1 to 6, the percentage of women using a contraceptive method increased from 58% to 80% among HIV-1-infected adults on zidovudine + lamivudine + efavirenz.

Côte d'IvoireVIH/sidaobserved months 1 to 6published 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/01.qai.0000219777.04927.50

16.7 %Overall, 16.7% of HIV-2 patients on ART had an advanced clinical stage (WHO IV or CDC-C).

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

60 %Among 1825 HIV-2-infected individuals initiating antiretroviral therapy, 60% were women.

Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations

9.6 %HIV prevalence was 9.6% among TB cases among inmates at the Correctional and Detention Facility of Abidjan.

Côte d'Ivoiretuberculose · VIH/sidaobserved 2015published 2017PloS oneeurope_pmcdocument of 8 observations

68.5 %The 36-month survival rate among ART-experienced HIV-2 patients with drug-resistant viruses was 68.5%.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

32.3 %A total of 10 (32.3%) HIV-2 patients died during follow-up.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

66.7 %Two-third of the HIV-2 patients were men.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

7.2 %Among the 597 patients who attended the M24 visit, the proportion who were obese increased from 7.2% to 9.2%.

Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations

5.5 per_100_person-yearsIn a cohort of HIV-infected patients of sub-Saharan African origin, the incidence of metabolic syndrome was 5.5 per 100 person-years of follow-up after 3 years of combined antiretroviral therapy.

Côte d'Ivoiresyndrome métabolique · VIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations

Among HBsAg-positive individuals, anti-HDV antibody positivity was 28.6% in HIV-1 patients, 14.3% in HIV-2 patients, and 0.0% in HIV-1&2 dually reactive patients.

Côte d'Ivoirehepatitis Delta virus · VIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations

20.4 %Among the 597 patients who attended the M24 visit, the proportion who were overweight increased from 20.4% to 24.8%.

Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations

126 cells/mm³In ART-treated patients, the CD4 count increased by 126 cells/mm³ after 24 months on ART for HIV-2 patients.

Côte d'IvoireVIH/sidaobserved 24 monthspublished 2013PloS oneeurope_pmcdocument of 14 observations

3.82 adjusted_IRRHBsAg-positive individuals with HBV-DNA ≥2000 IU/mL had an adjusted incidence rate ratio for mortality of 3.82 (95% CI = 1.11–9.70) at CD4+ counts ≤350/mm³ compared to HBsAg-negative individuals.

Côte d'Ivoirehépatite B · VIH/sidapublished 2021Antiviral therapyeurope_pmcdocument of 4 observations

All 95 HIV-2 patients in the cohort were receiving boosted-lopinavir-based antiretroviral treatment regimen.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

733 patientsAmong the 1,754 patients, 733 were dually seropositive for HIV-1 and HIV-2.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations